Issue 3/2019

Pituitary tumor transforming gene binding factor (PBF) is required for androgen-induced prostate cancer proliferation and invasion (327 — 335)

Sheng-Quan Huang, Bao Wang, Qian-Jin Liao, Chong-Xing Shen,  Wei-Bing Li

DOI: 10.4149/neo_2018_180730N552

FBLN3 inhibited the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway (336 — 342)

Hai-Yan Mao, Si-Ping Liu, Gui-Mei Kong, Yuan Xu, Yong-Chen Xu, Guo-Zhuang Sun, Zhu Wang, Fang Han,  Jian-Dong Tong,  Ping Bo

DOI: 10.4149/neo_2018_180703N441

Development of a five-gene signature as a novel prognostic marker in ovarian cancer (343 — 349)

 Rui Wang, Xiang-Hua Ye, Xiao-Lei Zhao, Jun-Li Liu, Chun-Yan Zhang

DOI: 10.4149/neo_2018_180705N447

miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a (350 — 356)

Guo-Fu Li, Ying-Ying Cheng, Bao-Jun Li, Cui Zhang, Xue-Xin Zhang, Jun Su, Chao Wang, Liang Chang, Dong-Zhi Zhang, Chun-Lei Tan,  Ning Wang

DOI: 10.4149/neo_2018_180714N484

Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells (357 — 366)

Annekatrin Müller, Josephine Gasch, Kai Albring, Fritz Aberger, Harini Nivarthi, Manel Khemeri, Richard Moriggl,  Karl-Heinz Friedrich

DOI: 10.4149/neo_2018_180731N560

Liver kinase B1 suppresses the metastasis and angiogenesis of lung cancer: involvement of the Shh signaling pathway (367 — 376)

Guanqun Zheng, Kuiyuan Song,  Yue Zhao

DOI: 10.4149/neo_2018_180820N630

Ambra1 inhibits paclitaxel-induced apoptosis in breast cancer cells by modulating the Bim/mitochondrial pathway (377 — 385)

 Wei-Liang Sun, Li Wang, Jie Luo, Hua-Wei Zhu, Zheng-Wen Cai

DOI: 10.4149/neo_2018_180710N467

Long non-coding RNA HOXB-AS1 promotes proliferation, migration and invasion of glioblastoma cells via HOXB-AS1/miR-885-3p/HOXB2 axis (386 — 396)

Xiaozhong Chen, Lu-Qian Li, Xinyi Qiu,  Haitao Wu

DOI: 10.4149/neo_2018_180606N377

LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma (397 — 404)

Wu Li, Wei Xu, Jing-Song Song, Tian Wu,  Wei-Xing Wang

DOI: 10.4149/neo_2018_180720N504

Zonula occludens-1 associated nucleic acid binding protein plays an invasion-promoting role in bladder cancer (405 — 419)

Xuewen Xu, Kai You,  Bin Wu

DOI: 10.4149/neo_2018_180725N530

High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer (420 — 426)

Yi-wen Li, Bo Lei, Jia-wei Zou, Wen-zheng Wang, An-yue Chen, Jia-jun Zhang, Ying-qiang Fu,  Zhi-gao Li

DOI: 10.4149/neo_2018_180819N624

MicroRNA-363-3p/p21(Cip1/Waf1) axis is regulated by HIF-2α in mediating stemness of melanoma cells (427 — 436)

Tian Hao,  Cheng-Xin Li, Xiang-Yu Ding, Xiao-Jing Xing

DOI: 10.4149/neo_2018_180828N655

Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation (437 — 445)

Zili Lv, Rongquan He, Menglan Huang, Guoyu Zhao,  Jie Ma,  Gang Chen

DOI: 10.4149/neo_2018_180806N593

Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis (446 — 458)

 Dong Tang, Qi Wu, Zhongxu Yuan, Jiaming Xu, Hongpeng Zhang, Zhixiang Jin, Qi Zhang, Minghao Xu, Zheng Wang, Zhujiang Dai, Huiwen Fang, Zhen Li, Chaobiao Lin, Chunfeng Shi, Mengyue Xu, Xiaoming Sun,  Daorong Wang

DOI: 10.4149/neo_2018_180925N714

Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method (459 — 469)

 Hao Wang, Dongyuan Liu, Jun Yang

DOI: 10.4149/neo_2018_181008N746

APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis (470 — 480)

Zhi-Jie Bai, Qian Liu, Xin-Sheng Wang,  Wei-Ying Liu

DOI: 10.4149/neo_2018_181009N753

The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells (481 — 486)

Hua Xiao, Francois-Xavier Claret,  Qian Shen

DOI: 10.4149/neo_2018_181016N772

Prognosis related miRNAs, DNA methylation, and epigenetic interactions in lung adenocarcinoma (487 — 493)

Hu Liu,  Huaqian Zhao

DOI: 10.4149/neo_2018_181029N805

Significance of MRI in rectal carcinoma therapy optimization – correlation of preoperative T- and N-staging with definitive histopathological findings (494 — 498)

 Ľudovít Danihel jr., Ľudovít Danihel sr., Matúš Rajčok, Kristína Mosná, Víťazoslav Belan, Ivan Varga, Milan Schnorrer

DOI: 10.4149/neo_2018_180522N334

Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies (499 — 505)

 Vladimír Maisnar, Zdenka Stefanikova, Ivan Spicka, Ludek Pour, Jiří Minařík, Emilia Flochova, Jakub Radocha, Evžen Gregora, Natalia Stecova, Tomas Jelinek, Alexandra Jungova, Eva Kralikova, Lucie Brozova, Roman Hajek

DOI: 10.4149/neo_2018_180824N644